Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Bill Colston, Marc Stapley, Steve Howell, More

Bill Colston
Fluidigm has appointed Bill Colston to its board of directors. Colston has served as president of iCarbonX since March. He joined iCarbonX as chief operating officer in April 2018 following its acquisition of his prior company, and he is also on its board of directors. Prior to this, Colston was cofounder and CEO of HealthTell. He also previously served as scientific founder and CEO of QuantaLife, which originally developed the technology behind Bio-Rad's droplet digital PCR products.


Marc Stapley

Molecular diagnostic firm OncoCell MDx has appointed Marc Stapley to its board of directors. Stapley currently serves as president and CEO of Helix and is also a member of Glaukos' board of directors. Prior to Helix, Stapley served as executive VP at Illumina. At Illumina, he also served as chief administrative officer and CFO. Before Illumina, Stapley held executive finance positions at Pfizer and other large multinational companies.


Steve Howell

Arcis Biotechnology, a nucleic acid sample prep provider, has appointed Steve Howell as non-executive chairman of the board. Howell will replace Paul Foulger, who acted as chairman of the board on an interim basis. Howell is currently a professor of commercial innovation at King's College, London, a position he has held since 2015. Howell founded Innova Partnerships in 2006 and has previously served as director of business development at Alere and research director at Unipath.


For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.